NCT06963489Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Source: ClinicalTrials.gov · Last updated 11 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This multicenter, ambispective cohort study establishes a comprehensive multiomics biobank from five stroke centers, encompassing thrombi, intracranial blood, peripheral arterial/venous blood, and clinical-laboratory-imaging-follow-up data from patients with acute ischemic stroke with large vessel occlusion (AIS-LVO).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 28 Apr 2025
- Start date
- 27 Apr 2025
- Primary completion date
- 29 Feb 2028
- Lead sponsor
- First Affiliated Hospital of Wannan Medical College
- Diseases
- Stroke
- NCT number
- NCT06963489
What you commit to
- Study type: Observational
- Planned participants: 500
- From 27 Apr 2025 to the primary completion date, 29 Feb 2028
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients for whom biological samples cannot be obtained;
- Patients or their family members who refuse to sign the informed consent form.
Who the study is looking for
- Age over 18 years.
- Patients with intracranial and extracranial large vessel occlusion ischemic stroke confirmed by cerebrovascular angiography.
- Availability of complete clinical and follow-up information required for the study.
- Availability of blood and/or thrombus biological samples.
- Voluntary written informed consent signed by the patient or their family (1) For retrospectively enrolled patients, a "broad informed consent" was signed at the time of sample collection. Upon enrollment into the cohort, a follow-up phone call was made to confirm the informed consent.
- (2) For prospectively enrolled patients, informed consent for this study was signed at the time of enrollment by the patient or their family.
Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baotou Central Hospital Coordinator of this site? Confirm its status | Baotou | China | Recruiting |
| Capital medical university of Beijing Tiantan Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Henan | China | Recruiting |
| Affiliated Hospital of Shandong University of Traditional Chinese Medicine Hospital Coordinator of this site? Confirm its status | Jinan | China | Recruiting |
| The First Affiliated Hospital of Shihezi University Coordinator of this site? Confirm its status | Wuhu | China | Not yet recruiting |
Related publications
- Cerebral large vessel occlusion stroke multiomics biosample cohort (CLOMB): a multicentre cohort protocol.Stroke Vasc Neurol · 2026 · PMID 42567544
This page is information, not medical advice. Discuss any trial with your doctor.